Rodrigo Abensur Athanazio

About Rodrigo Abensur Athanazio

Rodrigo Abensur Athanazio, With an exceptional h-index of 26 and a recent h-index of 22 (since 2020), a distinguished researcher at Universidade de São Paulo, specializes in the field of Pneumologia, Bronquiectasia, Fibrose Cística, Asma.

His recent articles reflect a diverse array of research interests and contributions to the field:

Elexacaftor/Tezacaftor/Ivacaftor effectiveness in N1303K variant in adult people with Cystic Fibrosis

Rate of severe exacerbations, healthcare resource utilisation and clinical outcomes in patients with COPD in low-income and middle-income countries: results from the EXACOS …

Rheumatoid arthritis-associated airway disease: longitudinal pulmonary function behavior

Doença de vias aéreas associada à artrite reumatoide: comportamento longitudinal da função pulmonar

Uso de elexacaftor+ tezacaftor+ ivacaftor em indivíduos com fibrose cística com pelo menos um alelo F508del: revisão sistemática e meta-análise

A BEAT-PCD consensus statement: a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia

Brazilian guidelines for the pharmacological treatment of the pulmonary symptoms of cystic fibrosis. Official document of the Sociedade Brasileira de Pneumologia e Tisiologia …

Diretrizes brasileiras para o tratamento farmacológico pulmonar na fibrose cística. Documento oficial da Sociedade Brasileira de Pneumologia e Tisiologia

Rodrigo Abensur Athanazio Information

University

Position

Médico Assistente do Serviço de Pneumologia do Instituto do Coração (InCor) do Hospital das Clínicas

Citations(all)

2194

Citations(since 2020)

1487

Cited By

1200

hIndex(all)

26

hIndex(since 2020)

22

i10Index(all)

48

i10Index(since 2020)

37

Email

University Profile Page

Google Scholar

Rodrigo Abensur Athanazio Skills & Research Interests

Pneumologia

Bronquiectasia

Fibrose Cística

Asma

Top articles of Rodrigo Abensur Athanazio

Elexacaftor/Tezacaftor/Ivacaftor effectiveness in N1303K variant in adult people with Cystic Fibrosis

Archivos de Bronconeumología

2024/4/24

Rodrigo Abensur Athanazio
Rodrigo Abensur Athanazio

H-Index: 14

Rate of severe exacerbations, healthcare resource utilisation and clinical outcomes in patients with COPD in low-income and middle-income countries: results from the EXACOS …

BMJ Open Respiratory Research

2024/4/1

Rodrigo Abensur Athanazio
Rodrigo Abensur Athanazio

H-Index: 14

Manuel Pacheco
Manuel Pacheco

H-Index: 4

Rheumatoid arthritis-associated airway disease: longitudinal pulmonary function behavior

Jornal Brasileiro de Pneumologia

2024/2/23

Doença de vias aéreas associada à artrite reumatoide: comportamento longitudinal da função pulmonar

Jornal Brasileiro de Pneumologia

2024/2/23

Uso de elexacaftor+ tezacaftor+ ivacaftor em indivíduos com fibrose cística com pelo menos um alelo F508del: revisão sistemática e meta-análise

2024/1/5

Rodrigo Abensur Athanazio
Rodrigo Abensur Athanazio

H-Index: 14

Juliana Carvalho Ferreira
Juliana Carvalho Ferreira

H-Index: 16

A BEAT-PCD consensus statement: a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia

ERJ open research

2024/1/1

Brazilian guidelines for the pharmacological treatment of the pulmonary symptoms of cystic fibrosis. Official document of the Sociedade Brasileira de Pneumologia e Tisiologia …

Jornal Brasileiro de Pneumologia

2020/3/2

Diretrizes brasileiras para o tratamento farmacológico pulmonar na fibrose cística. Documento oficial da Sociedade Brasileira de Pneumologia e Tisiologia

Jornal Brasileiro de Pneumologia

2020/3/2

Exercise Capacity as a Predictor of 3-year Mortality in Adult Bronchiectasis Patients

2023/5

Post-TB bronchiectasis: from pathogenesis to rehabilitation

The International Journal of Tuberculosis and Lung Disease

2023/3/1

Changes after 12 years of follow-up severe asthma patients cohort: higher obstruction and comorbidities, but significant better quality of life

Journal of Asthma

2023/2/1

Fibrose cística é um fator de risco para infecção por COVID-19 ou suas complicações?

2023/1/13

Use of elexacaftor+ tezacaftor+ ivacaftor in individuals with cystic fibrosis and at least one F508del allele: a systematic review and meta-analysis

2023

Rodrigo Abensur Athanazio
Rodrigo Abensur Athanazio

H-Index: 14

Juliana Carvalho Ferreira
Juliana Carvalho Ferreira

H-Index: 16

A real-life study of elexacaftor-tezacaftor-ivacaftor therapy in people with cystic fibrosis in Brazil

Pulmonology

2023

Computed Tomography Evaluation of the Paranasal Sinuses in Adults with Primary Ciliary Dyskinesia

International archives of otorhinolaryngology

2023/1

A study of the psychometric properties of the Brazilian... Portuguese version of Bronchiectasis Health Questionnaire

Pulmonology

2023/1/1

Use of elexacaftor plus tezacaftor plus ivacaftor in individuals with cystic fibrosis and at least one F508del allele: a systematic review and meta-analysis

JORNAL BRASILEIRO DE PNEUMOLOGIA

2023/11/1

Rodrigo Abensur Athanazio
Rodrigo Abensur Athanazio

H-Index: 14

Juliana Carvalho Ferreira
Juliana Carvalho Ferreira

H-Index: 16

Outcomes of Endoscopic Sinus Surgery for Chronic Rhinosinusitis in Adults with Primary Ciliary Dyskinesia

International Archives of Otorhinolaryngology

2023/7

In-person and online application of the Bronchiectasis Health Questionnaire: are they interchangeable?

Jornal Brasileiro de Pneumologia

2022/7/8

Prevalence of the eosinophilic phenotype among severe asthma patients in Brazil: the BRAEOS study

Jornal Brasileiro de Pneumologia

2022/7/8

See List of Professors in Rodrigo Abensur Athanazio University(Universidade de São Paulo)